litlas
Log inCreate account

C. Blake Gilks

Active 1989–2025

Also published as
C Blake Gilks · C Blake-Gilks
303
Papers
49,264
Citations
126
h-index
291
i10-index

Citations

Citations per year for C. Blake Gilks1990: 1 citations1991: 4 citations1992: 1 citations1993: 2 citations1994: 7 citations1995: 5 citations1996: 8 citations1997: 14 citations1998: 11 citations1999: 17 citations2000: 27 citations2001: 25 citations2002: 54 citations2003: 57 citations2004: 101 citations2005: 134 citations2006: 174 citations2007: 182 citations2008: 255 citations2009: 249 citations2010: 371 citations2011: 416 citations2012: 471 citations2013: 494 citations2014: 413 citations2015: 458 citations2016: 535 citations2017: 590 citations2018: 547 citations2019: 1,604 citations2020: 2,010 citations2021: 1,846 citations2022: 1,648 citations2023: 1,197 citations2024: 1,899 citations2025: 822 citations2026: 26 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,414 citing papers, 25.2% of this breakdownChina: 1,600 citing papers, 9.2% of this breakdownUnited Kingdom: 1,346 citing papers, 7.7% of this breakdownCanada: 1,246 citing papers, 7.1% of this breakdownItaly: 827 citing papers, 4.7% of this breakdownGermany: 731 citing papers, 4.2% of this breakdownFrance: 616 citing papers, 3.5% of this breakdownJapan: 598 citing papers, 3.4% of this breakdownAustralia: 582 citing papers, 3.3% of this breakdownNetherlands: 531 citing papers, 3% of this breakdownSpain: 518 citing papers, 3% of this breakdownSwitzerland: 290 citing papers, 1.7% of this breakdown
0%25.2%Other 24%

Institutions

Fields

  • Medicine59.7%
  • Biochemistry, Genetics and Molecular Biology29.7%
  • Immunology and Microbiology5.7%
  • Computer Science2.4%
  • Engineering0.7%
  • Neuroscience0.4%
  • Other1.4%

Topics

  • Ovarian cancer diagnosis and treatment7.3%
  • Endometrial and Cervical Cancer Treatments5.3%
  • Cancer Genomics and Diagnostics3.4%
  • Cancer Immunotherapy and Biomarkers3.1%
  • PARP inhibition in cancer therapy2.8%
  • Breast Cancer Treatment Studies1.9%
  • Other76.2%

Coauthors

All papers

Open in search
  1. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

    Authors: Andrea Facciabene, Xiaohui Peng, Ian S. Hagemann, Klara Balint, Andrea Barchetti, Liping Wang, Phyllis A. Gimotty, C. Blake Gilks, Priti Lal, Lin Zhang, George Coukos - Nature 2011 cited by 1,372

  2. Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer

    Authors: Aline Talhouk, Melissa K. McConechy, Samuel Leung, Winnie Yang, Amy Lum, Janine Senz, Niki Boyd, J.A. Pike, Michael S. Anglesio, Janice S. Kwon, Anthony N. Karnezis, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine - Cancer 2017 cited by 960

  3. A clinically applicable molecular-based classification for endometrial cancers

    Authors: Aline Talhouk, Melissa K. McConechy, Samuel Leung, Hector Li-Chang, Janice S. Kwon, Nataliya Melnyk, Winnie Yang, Janine Senz, Niki Boyd, Anthony N. Karnezis, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine - British Journal of Cancer 2015 cited by 944

  4. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

    Authors: Stefan Kommoss, Melissa K. McConechy, F. Kommoss, Samuel Leung, Anne-Kathrin Bunz, Jamie Magrill, Heidi Britton, F. Kommoss, Friederike Grevenkamp, Anthony N. Karnezis, Winnie Yang, Amy Lum, B. Krämer, Florin‐Andrei Taran, Annette Staebler, S. Lax, S Brücker, David G. Huntsman, C. Blake Gilks, Jessica N. McAlpine, Aline Talhouk - Annals of Oncology 2018 cited by 756

  5. ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

    Authors: Kimberly C. Wiegand, Sohrab P. Shah, Osama M. Al‐Agha, Yongjun Zhao, Kane Tse, Thomas Zeng, Janine Senz, Melissa K. McConechy, Michael S. Anglesio, Steve E. Kalloger, Winnie Yang, Alireza Heravi‐Moussavi, Ryan Giuliany, Christine Chow, John Fee, Abdalnasser Zayed, Leah Prentice, Nataliya Melnyk, Gulisa Turashvili, Allen Delaney, Jason Madore, Stephen Yip, Andrew McPherson, Gavin Ha, Lynda Bell, Sián Fereday, Angela Tam, Laura Galletta, Patricia N. Tonin, Diane Provencher, Dianne Miller, Steven J.M. Jones, Richard A. Moore, Gregg B. Morin, Arusha Oloumi, Niki Boyd, Samuel Aparício, Ie Ming Shih, Anne‐Marie Mes‐Masson, David D.L. Bowtell, Martin Hirst, C. Blake Gilks, Marco A. Marra, David G. Huntsman - New England Journal of Medicine 2010 cited by 1,702

  6. Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

    Authors: Alicia León‐Castillo, Ester Gilvazquez, Remi A. Nout, Vincent T.H.B.M. Smit, Jessica N. McAlpine, Melissa K. McConechy, Stefan Kommoss, Sara Y. Brucker, Joseph W. Carlson, E. Epstein, Tilman T. Rau, Robert A. Soslow, Raji Ganesan, Xavier Matías‐Guiu, Esther Oliva, Beth Harrison, David N. Church, C. Blake Gilks, Tjalling Bosse - The Journal of Pathology 2019 cited by 402

  7. Interpretation of somatic POLE mutations in endometrial carcinoma

    Authors: Alicia León‐Castillo, Heidi Britton, Melissa K. McConechy, Jessica N. McAlpine, Remi A. Nout, Stefan Kommoss, Sara Y. Brucker, Joseph W. Carlson, E. Epstein, Tilman T. Rau, Tjalling Bosse, David N. Church, C. Blake Gilks - The Journal of Pathology 2019 cited by 392

  8. Cancer-Associated Mutations in Endometriosis without Cancer

    Authors: Michael S. Anglesio, Nickolas Papadopoulos, A. Ayhan, Tayyebeh M. Nazeran, Michaël Noë, Hugo M. Horlings, Amy Lum, Siân Jones, Janine Senz, Tamer Seckin, Julie Ho, Ren‐Chin Wu, Vivian Lac, Hiroshi Ogawa, Basile Tessier‐Cloutier, Rami Alhassan, Amy Wang, Yuxuan Wang, Joshua D. Cohen, Fontayne Wong, Adnan Hasanovic, Natasha L. Orr, Ming Zhang, Maria Popoli, Wyatt McMahon, Laura D. Wood, Austin K. Mattox, Catherine Allaire, James H. Segars, Christina Williams, Cristian Tomasetti, Niki Boyd, Kenneth W. Kinzler, C. Blake Gilks, Luis A. Díaz, Tian‐Li Wang, Bert Vogelstein, Paul J. Yong, David G. Huntsman, Ie‐Ming Shih - New England Journal of Medicine 2017 cited by 623

  9. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

    Authors: Naveena Singh, Anna Piskorz, Tjalling Bosse, Mercedes Jimenez‐Liñan, Brian Rous, James D. Brenton, C. Blake Gilks, Martin Köbel - The Journal of Pathology 2019 cited by 298

  10. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

    Authors: Tjalling Bosse, Remi A. Nout, Jessica N. McAlpine, Melissa K. McConechy, Heidi Britton, Yaser Hussein, Carlene Gonzalez, Raji Ganesan, Jane C. Steele, Beth Harrison, Esther Oliva, August Vidal, Xavier Matías‐Guiu, Nadeem R. Abu‐Rustum, Douglas A. Levine, C. Blake Gilks, Robert A. Soslow - The American Journal of Surgical Pathology 2018 cited by 342

  11. Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility

    Authors: Martin Köbel, Brigitte M. Ronnett, Naveena Singh, Robert A. Soslow, C. Blake Gilks, W. Glenn McCluggage - International Journal of Gynecological Pathology 2018 cited by 398

  12. Synthesis of diagnostic quality cancer pathology images by generative adversarial networks

    Authors: Adrian Levine, Jason Peng, David Farnell, Mitchell Nursey, Yiping Wang, Julia Naso, Hezhen Ren, Hossein Farahani, Colin Chen, Derek S. Chiu, Aline Talhouk, Brandon S. Sheffield, Maziar Riazy, Philip P.C. Ip, Carlos Parra‐Herran, Anne M. Mills, Naveena Singh, Basile Tessier‐Cloutier, Taylor Salisbury, Jonathan Lee, Tim Salcudean, Steven J.M. Jones, David G. Huntsman, C. Blake Gilks, Stephen Yip, Ali Bashashati - The Journal of Pathology 2020 cited by 123

  13. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

    Authors: Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli, Robert A. Vierkant, Wenqian Chen, Zachary C. Fogarty, Aleksandra Gentry‐Maharaj, Aleksandra Tołoczko, Alexander Hein, Aliecia L. Bouligny, Allan Jensen, Ana Osório, Andreas D. Hartkopf, Andy Ryan, Anita Chudecka-Głaz, Anthony M. Magliocco, Arndt Hartmann, Audrey Jung, Bo Gao, Brenda Y. Hernandez, Brooke L. Fridley, Bryan M. McCauley, Catherine J. Kennedy, Chen Wang, Chloe Karpinskyj, Christiani Bisinoto de Sousa, Daniel Guimarães Tiezzi, David L. Wachter, Esther Herpel, Florin‐Andrei Taran, Francesmary Modugno, Gregg Nelson, Jan Lubiński, Janusz Menkiszak, Jennifer Alsop, Jenny Lester, Jesús García-Donás, Jill Nation, Jillian A. Hung, José Palacios, Joseph H. Rothstein, Joseph L. Kelley, Jurandyr Moreira de Andrade, Luis A. Díaz‐Robles, Maria P. Intermaggio, Martin Widschwendter, Matthias W. Beckmann, Matthias Ruebner, Mercedes Jimenez‐Liñan, Naveena Singh, Oleg Oszurek, Paul R. Harnett, Peter Rambau, Hans‐Peter Sinn, Philipp Wagner, Prafull Ghatage, Raghwa Sharma, Robert P. Edwards, Roberta B. Ness, Sandra Oršulić, Sara Y. Brucker, Sharon E. Johnatty, Teri A. Longacre, Ursula Eilber, Valerie McGuire, Weiva Sieh, Yanina Natanzon, Zheng Li, Alice S. Whittemore, Anna DeFazio, Annette Staebler, Beth Y. Karlan, C. Blake Gilks, David D.L. Bowtell, Estrid Høgdall, Francisco José Cândido dos Reis, Helen Steed, Ian Campbell, Jacek Gronwald, Javier Benı́tez, Jennifer M. Koziak, Jenny Chang‐Claude, Kirsten B. Moysich, Linda E. Kelemen, Linda S. Cook, Marc T. Goodman, María J. García, Peter A. Fasching, Stefan Kommoss, Suha Deen, Susanne K. Kjær, Usha Menon, James D. Brenton, Paul D.P. Pharoah, Georgia Chenevix‐Trench, David G. Huntsman, Stacey J. Winham, Martin Köbel, Susan J. Ramus - JAMA Oncology 2017 cited by 404

  14. Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer

    Authors: Allen W. Zhang, Andrew McPherson, Katy Milne, David R. Kroeger, Phineas T. Hamilton, Alex Miranda, Tyler Funnell, Nicole S. Little, Camila P. E. de Souza, Sonya Laan, Stacey Ledoux, Dawn R. Cochrane, Jamie Lim, Winnie Yang, Andrew Roth, Maia A. Smith, Julie Ho, Kane Tse, Thomas Zeng, Inna Shlafman, Michael R. Mayo, Richard A. Moore, Henrik Failmezger, Andreas Heindl, Yi Kan Wang, Ali Bashashati, Diljot Grewal, Scott D. Brown, Daniel Lai, Adrian Wan, Cydney Nielsen, Curtis Huebner, Basile Tessier‐Cloutier, Michael S. Anglesio, Alexandre Bouchard‐Côté, Yinyin Yuan, Wyeth W. Wasserman, C. Blake Gilks, Anthony N. Karnezis, Samuel Aparício, Jessica N. McAlpine, David G. Huntsman, Robert A. Holt, Brad H. Nelson, Sohrab P. Shah - Cell 2018 cited by 387

  15. Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images

    Authors: Hossein Farahani, Jeffrey Boschman, David Farnell, Amirali Darbandsari, Allen Zhang, Pouya Ahmadvand, Steven J.M. Jones, David G. Huntsman, Martin Köbel, C. Blake Gilks, Naveena Singh, Ali Bashashati - Modern Pathology 2022 cited by 85

  16. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis

    Authors: Jessica N. McAlpine, Derek S. Chiu, Remi A. Nout, David N. Church, Pascal Schmidt, Stéphanie Lam, Samuel Leung, Stefania Bellone, Adele Wong, Sara Y. Brucker, Cheng‐Han Lee, Blaise Clarke, David G. Huntsman, Marcus Q. Bernardini, Joanne Ngeow, Alessandro D. Santin, Paul J. Goodfellow, Douglas A. Levine, Martin Köbel, Stefan Kommoss, Tjalling Bosse, C. Blake Gilks, Aline Talhouk - Cancer 2021 cited by 156

  17. Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death

    Authors: Amy Jamieson, Jutta Huvila, Derek S. Chiu, Emily F. Thompson, Stephanie Scott, Shannon Salvador, Danielle Vicus, Limor Helpman, Walter H. Gotlieb, Sarah Kean, Vanessa Samouëlian, Martin Köbel, Mary Kinloch, Carlos Parra-Harran, Saul Offman, Katherine Grondin, Julie Irving, Amy Lum, Janine Senz, Samuel Leung, Melissa K. McConechy, Marie Plante, Stefan Kommoss, David G. Huntsman, Aline Talhouk, C. Blake Gilks, Jessica N. McAlpine - Modern Pathology 2023 cited by 104

  18. Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

    Authors: Karama Asleh, Gian Luca Negri, Sandra E. Spencer Miko, Shane Colborne, Christopher S. Hughes, Xiu Q. Wang, Dongxia Gao, C. Blake Gilks, Stephen Chia, Torsten O. Nielsen, Gregg B. Morin - Nature Communications 2022 cited by 133

  19. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data

    Authors: Gavin Ha, Andrew Roth, Jaswinder Khattra, Julie Ho, Damian Yap, Leah Prentice, Nataliya Melnyk, Andrew McPherson, Ali Bashashati, Emma Laks, Justina Biele, Jiarui Ding, Alan Le, Jamie Rosner, Karey Shumansky, Marco A. Marra, C. Blake Gilks, David G. Huntsman, Jessica N. McAlpine, Samuel Aparício, Sohrab P. Shah - Genome Research 2014 cited by 429

  20. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists

    Authors: Robert A. Soslow, Carmen Tornos, Kay J. Park, Anaís Malpica, Xavier Matías‐Guiu, Esther Oliva, Vinita Parkash, Joseph W. Carlson, W. Glenn McCluggage, C. Blake Gilks - International Journal of Gynecological Pathology 2018 cited by 317

  21. Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

    Authors: Katy Milne, Martin Köbel, Steven E. Kalloger, Rebecca Barnes, Dongxia Gao, C. Blake Gilks, Peter H. Watson, Brad H. Nelson - PLoS ONE 2009 cited by 435

  22. The utility of color normalization for AI‐based diagnosis of hematoxylin and eosin‐stained pathology images

    Authors: Jeffrey Boschman, Hossein Farahani, Amirali Darbandsari, Pouya Ahmadvand, Ashley Van Spankeren, David Farnell, Adrian Levine, Julia Naso, Andrew Churg, Steven J.M. Jones, Stephen Yip, Martin Köbel, David G. Huntsman, C. Blake Gilks, Ali Bashashati - The Journal of Pathology 2021 cited by 62

  23. Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma

    Authors: C. Blake Gilks, Esther Oliva, Robert A. Soslow - The American Journal of Surgical Pathology 2013 cited by 412

  24. FIGO 2023 endometrial cancer staging: too much, too soon?

    Authors: W. Glenn McCluggage, Tjalling Bosse, C. Blake Gilks, Brooke E. Howitt, Jessica N. McAlpine, Marisa R. Nucci, Joseph T. Rabban, Naveena Singh, Karen L. Talia, Carlos Parra‐Herran - International Journal of Gynecological Cancer 2023 cited by 79